G9209 — Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
G9209 is a HCPCS Level II code for hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment. It belongs to the Procedures and Professional Services (Temporary) section. It was terminated on December 31, 2016 and is not valid on new claims.
This code has been terminated
CMS terminated G9209 on December 31, 2016. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for G9209
- Long descriptor
- Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
- Short descriptor
- Hep c rna 4to12 wk after med
- Added
- January 1, 2014
- Terminated
- December 31, 2016
- BETOS
- M5B
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to G9209
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G9209 is not quite right, the correct code is very often within a few positions of it.
- G9201Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admissionterminated
- G9202Patients with a positive hepatitis c antibody testterminated
- G9203Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis cterminated
- G9204Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not giventerminated
- G9205Patient starting antiviral treatmentfor hepatitis c during the measurement periodterminated
- G9206Patient starting antiviral treatment for hepatitis c during the measurement periodterminated
- G9207Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis cterminated
- G9208Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not giventerminated
- G9210Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)terminated
- G9211Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not giventerminated
- G9212Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
- G9213Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified
- G9214Cd4+ cell count or cd4+ cell percentage results documentedterminated
- G9215Cd4+ cell count or percentage not documented as performed, reason not giventerminated
- G9216Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not giventerminated
- G9217Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not giventerminated
Questions about G9209
What is HCPCS code G9209?
G9209 is a HCPCS Level II code for hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment. It sits in the Procedures and Professional Services (Temporary) section.
Does Medicare cover G9209?
The CMS HCPCS file marks G9209 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is G9209 still valid?
No. G9209 was terminated on December 31, 2016 and should not be used on new claims.